PATENT CLAIM ANALYSIS

Application Number: 16011063
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "062000"]

Abstract:
The present invention provides dosing regimens for administering pharmacological chaperones to a subject in need thereof. The dosing regimens can be used to treat disorders caused by improper protein misfolding, such as lysosomal storage disorders.

Claim (Index 21):
A method for treatment of Fabry disease in a human patient in need thereof, the method comprising administering to the patient a therapeutically effective dose of 1-deoxygalactonojirimycin or a salt thereof, wherein the therapeutically effective dose provides one or more of:\n a. a mean maximum drug plasma concentration (C max ) of about 9 \u03bcM; b. a mean time to maximum drug plasma concentration (T max ) of about 3 hours; or c. a mean drug plasma half-life (t 1/2 ) of about 3 hours.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16011068', '15213920', '12597238', '14054369', '12855468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7981605161834027
- 35 USC 102 Novelty (BERT): 0.7058598077665167
- Combined Prediction Score: 0.7889304453417141
- Mean Citation Score: 582.5836959999998
- Max Citation Score: 739.6668
- Similarity Product: 728.3658314218998

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test